Cancer clinical trials cooperative groups are in jeopardy, and changes are needed to enable the system to survive, chairmen of the groups wrote in a paper submitted to NCI. White paper makes 25 recommendations, including changing system incentives, review process, group integration with centers and SPOREs, and inclusion in CaBIG. This 8-page issue includes full text of the white paper.
Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.
Peter Jones begins term as AACR president-elect. New directors elected.
AACR honors Emil Frei III for pioneering work in childhood leukemia.
Trending Stories
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Trump 2016: A look back at the 45th president’s impact on oncology
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills